Impact of the COVID-19 Pandemic on HPV Vaccination in Low- and Middle-Income Countries: A Scoping Review
Vaccines · 12.05.2026 · 14 (5) · 432
DOI: 10.3390/vaccines14050432 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 12.05.2026. Verfasst von Joyce Omondi und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Saskatchewan, OPVPA.
Abstract (Originalsprache)
Background
The COVID-19 pandemic caused disruptions in HPV vaccination and may have severely undermined global cervical cancer prevention, posing long-term risks to controlling cervical cancer and other HPV-related diseases.
Objective
We conducted a scoping review to map and synthesize available evidence on how the COVID-19 pandemic has affected human papillomavirus (HPV) vaccination programs in low- and middle-income countries (LMICs) focusing on changes in vaccine delivery and coverage, determinants of uptake, economic and programmatic consequences and vaccine hesitancy.
Methods
Inclusion criteria were limited to studies published in the English language between January 2020 to May 2025, and followed JBI and Arksey & O’Malley’s scoping review guidelines. The review proceeded through three stages: database searches, gray literature and citation tracking and used a PRISMA-ScR checklist to guide narrative and tabular synthesis.
Results
A total of 1063 records, 57 studies were included in the final analysis, and these were spread out across 37 low- and middle-income countries (LMICs) mainly in Africa, Asia, and Latin America. Our analysis revealed that HPV vaccination coverage declined substantially during the COVID-19 pandemic, with reductions of up to 90% reported across the included studies, in the context of school closures, workforce redeployment, and supply-chain disruptions. Recovery efforts also faced major barriers including vaccine hesitancy, misinformation about COVID-19 vaccines, and travel restrictions. Strategies like digital tools, mobile clinics, and community health workers showed promise alongside integrated school- and facility-based approaches, although there is limited evidence on cost-effectiveness and long-term sustainability of these strategies.
Conclusions
HPV vaccination in LMICs was significantly disrupted by the COVID-19 pandemic due to unreliable vaccine supply chains, health-worker shortages, and challenges tied to school-based vaccine delivery. Although recovery methods show potential, longer observation periods are needed to determine their full effectiveness.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Public Health, University of Saskatchewan, Saskatoon, SK S7N 5E5, Canada.
- School of Public Administration and Development Economics, Doha Institute for Graduate Studies, Doha P.O. Box 200592, Qatar.
ORCID-Profile: Joyce Omondi, Robert Ambogo, Candy Ochieng
Förderung
- University of Saskatchewan, OPVPA
Zitieren
APA
Omondi, J., Ambogo, R., Ochieng, C., Farag, M., & Mutwiri, G. (2026). Impact of the COVID-19 Pandemic on HPV Vaccination in Low- and Middle-Income Countries: A Scoping Review. Vaccines, 14(5), 432. https://doi.org/10.3390/vaccines14050432
Vancouver
Omondi J, Ambogo R, Ochieng C, Farag M, Mutwiri G. Impact of the COVID-19 Pandemic on HPV Vaccination in Low- and Middle-Income Countries: A Scoping Review. Vaccines. 2026;14(5):432. doi:10.3390/vaccines14050432
BibTeX
@article{Omondi2026,
author = {Omondi, Joyce and Ambogo, Robert and Ochieng, Candy and Farag, Marwa and Mutwiri, George},
title = {Impact of the COVID-19 Pandemic on HPV Vaccination in Low- and Middle-Income Countries: A Scoping Review},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {5},
pages = {432},
doi = {10.3390/vaccines14050432}
}
EUVIMED